Interpace Diagnostics Group Mutual Funds

Business & Consumer Services » Business Services | Interpace Diagnostics Group Inc.

Interpace Diagnostics Group Inc. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Total Stock Market Index Fund

612,138

2.17%

07/31/2018

Vanguard Extended Market Index Fund

241,321

0.86%

07/31/2018

Fidelity Spartan Extended Market Index Fund

84,688

0.3%

07/31/2018

Fidelity Nasdaq Composite Index

50,899

0.18%

07/31/2018

Vanguard Balanced Index Fund

12,513

0.04%

07/31/2018

7,307

0.03%

0.04%

09/05/2018

iShares Core S&P Total US Stock Market ETF

271

09/06/2018

Fidelity Spartan Total Market Index Fund

136

07/31/2018

View Profile

Address	Morris Corporate Center 1 Parsippany New Jersey 07054 United States
Employees	-
Website	http://www.interpacediagnostics.com
Updated	07/08/2019
Interpace Diagnostics Group, Inc. is an bioinformatics company, which engages in the development and commercialization of molecular diagnostic test and pathology services. It offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion molecular test that can aid in pancreatic cyst diagnosis and pancreatic cancer risk assessment; ThyGenX and PathFinderTG which assesses thyroid nodules for risk of malignancy; and ThyraMIR, which assesses thyroid nodules for risk of malignancy utilizing a proprietary gene expression assay. The company was founded by John P.